SCHEMBL5140764

SCHEMBL5140764

c1ccc(OCCN2CCC(Nc3nccc4[nH]ncc34)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.47
HTR7 P34969 8/20 0.47
KDM1A O60341 4/20 0.46
GRIN2B Q13224 1/20 0.45
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CCNA2 P20248 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
CCND3 P30281 1/20 0.43
CDK6 Q00534 1/20 0.43
DRD2 P14416 3/20 0.42
HTR6 P50406 1/20 0.42
ROCK2 O75116 1/20 0.42
CHRM1 P11229 1/20 0.41
KCNH2 Q12809 1/20 0.41
BRD4 O60885 1/20 0.41
ATAD2 Q6PL18 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4313437 0.85 GRIN2B (0.58) GRIN2BKCNH2
SCHEMBL5140457 0.81 GRIN2B (0.45) GRIN2BSIGMAR1ROCK2KCNH2
SCHEMBL5142207 0.79 GRIN2B (0.46) GRIN2BROCK2KCNH2
SCHEMBL5140958 0.79 GRIN2B (0.44) GRIN2BROCK2KCNH2
SCHEMBL5141563 0.77 GRIN2B (0.54) GRIN2BROCK2KCNH2
SCHEMBL13633473 0.77 HTR1A (0.54) HTR1AHTR7KDM1ATMEM97SIGMAR1
SCHEMBL5167369 0.77 GRIN2B (0.59) GRIN2BKCNH2
SCHEMBL13633424 0.76 HTR1A (0.52) HTR1AHTR7KDM1ATMEM97SIGMAR1
SCHEMBL5173287 0.74 ROCK2 (0.45) GRIN2BDRD2ROCK2KCNH2DRD3
SCHEMBL3769138 0.73 HPGDS (0.60) CDK1CDK4CCNA2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874318-A2 N-ALKYL-AZACYCLOALKYL NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2008-01-09 EP disclosed
WO-2006113471-A2 N-ALKYL-AZACYCLOALKYL NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2006-10-26 WO disclosed